JAK V617F missense mutation is absent in pancreatic cancer
AUTOR(ES)
Kocher, H M
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955495Documentos Relacionados
- The JAK2 V617F mutation in Philadelphia‐negative chronic myeloproliferative disorders
- A mutação JAK2 V617F e as síndromes mieloproliferativas
- Infrequent V617F mutation of the JAK2 gene in myeloid leukemia and its absence in lymphoid malignancies in Japan
- JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
- Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F